These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20383176)

  • 41. Role of Receptor Interacting Protein (RIP) kinases in cancer.
    Ermine K; Yu J; Zhang L
    Genes Dis; 2022 Nov; 9(6):1579-1593. PubMed ID: 36157481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    Holler N; Zaru R; Micheau O; Thome M; Attinger A; Valitutti S; Bodmer JL; Schneider P; Seed B; Tschopp J
    Nat Immunol; 2000 Dec; 1(6):489-95. PubMed ID: 11101870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.
    Meurette O; Rebillard A; Huc L; Le Moigne G; Merino D; Micheau O; Lagadic-Gossmann D; Dimanche-Boitrel MT
    Cancer Res; 2007 Jan; 67(1):218-26. PubMed ID: 17210702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.
    Sun X; Yin J; Starovasnik MA; Fairbrother WJ; Dixit VM
    J Biol Chem; 2002 Mar; 277(11):9505-11. PubMed ID: 11734559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain.
    Feng S; Yang Y; Mei Y; Ma L; Zhu DE; Hoti N; Castanares M; Wu M
    Cell Signal; 2007 Oct; 19(10):2056-67. PubMed ID: 17644308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.
    Lin Y; Devin A; Rodriguez Y; Liu ZG
    Genes Dev; 1999 Oct; 13(19):2514-26. PubMed ID: 10521396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.
    Villunger A; Huang DC; Holler N; Tschopp J; Strasser A
    J Immunol; 2000 Aug; 165(3):1337-43. PubMed ID: 10903735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death.
    Shen HM; Lin Y; Choksi S; Tran J; Jin T; Chang L; Karin M; Zhang J; Liu ZG
    Mol Cell Biol; 2004 Jul; 24(13):5914-22. PubMed ID: 15199146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RIP-in CD95-induced cell death: The control of alternative death receptors pathways by cIAPs.
    Geserick P; Hupe M; Moulin M; Leverkus M
    Cell Cycle; 2010 Jul; 9(14):2689-91. PubMed ID: 20581447
    [No Abstract]   [Full Text] [Related]  

  • 50. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.
    Kelliher MA; Grimm S; Ishida Y; Kuo F; Stanger BZ; Leder P
    Immunity; 1998 Mar; 8(3):297-303. PubMed ID: 9529147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation.
    Chen D; Li X; Zhai Z; Shu HB
    J Biol Chem; 2002 May; 277(18):15985-91. PubMed ID: 11854271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RIP kinases as modulators of inflammation and immunity.
    He S; Wang X
    Nat Immunol; 2018 Sep; 19(9):912-922. PubMed ID: 30131615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of life and death by the TNF receptor superfamily.
    Baker SJ; Reddy EP
    Oncogene; 1998 Dec; 17(25):3261-70. PubMed ID: 9916988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB.
    Rebsamen M; Heinz LX; Meylan E; Michallet MC; Schroder K; Hofmann K; Vazquez J; Benedict CA; Tschopp J
    EMBO Rep; 2009 Aug; 10(8):916-22. PubMed ID: 19590578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RIP2, a checkpoint in myogenic differentiation.
    Munz B; Hildt E; Springer ML; Blau HM
    Mol Cell Biol; 2002 Aug; 22(16):5879-86. PubMed ID: 12138198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Sun J; Yu X; Wang C; Yu C; Li Z; Nie W; Xu X; Miao X; Jin X
    Med Sci Monit; 2017 Mar; 23():1190-1199. PubMed ID: 28270653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases.
    Shikama Y; Yamada M; Miyashita T
    Eur J Immunol; 2003 Jul; 33(7):1998-2006. PubMed ID: 12884866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of RIP3-dependent necroptosis by human cytomegalovirus.
    Omoto S; Guo H; Talekar GR; Roback L; Kaiser WJ; Mocarski ES
    J Biol Chem; 2015 May; 290(18):11635-48. PubMed ID: 25778401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.